FDA Inspection 1238387 — Novo Nordisk A/S - Hax

Novo Nordisk A/S - Hax — FEI 3002807748

The FDA completed an inspection of Novo Nordisk A/S - Hax on Jun 1, 2023 in Gentofte. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 1, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gentofte (Denmark)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.